Impressive phase III results from RESONATE in CLL

Impressive phase III results from RESONATE in CLL

User Photo
EMJ

6 years
2,916 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Prof. Peter Hillmen from Leeds Teaching Hospital, Leeds, UK, gives an update on the phase III results from the RESONATE study in 391 patients with relapsed refractory chronic lymphoid leukemia (CLL). Prof Hillmen outlines the PFS and OS results that showed the significant benefits of ibrutinib over ofatumumab. He comments on single vs. combination therapy with ibrutinib in CLL.
Up Next Autoplay